1T-AL-LAD
A psychedelic compound related to LSD
1T-AL-LAD (1-Tetrahydro-lysergic acid diethylamide) is a psychedelic compound that is structurally related to LSD (lysergic acid diethylamide). It belongs to the class of lysergamides, which are known for their potent effects on the human mind, often inducing altered states of consciousness, visual hallucinations, and changes in perception.
Chemical Structure and Properties[edit | edit source]
1T-AL-LAD is a derivative of LSD, with a chemical structure that includes a tetrahydrofuran ring. This modification distinguishes it from other lysergamides and contributes to its unique pharmacological profile. The molecular formula of 1T-AL-LAD is C24H31N3O2, and it has a molar mass of 393.53 g/mol.
Pharmacology[edit | edit source]
1T-AL-LAD acts primarily as a partial agonist at the 5-HT2A receptor, which is believed to be the primary mechanism through which it exerts its psychedelic effects. Like other lysergamides, it may also interact with other serotonin receptors, contributing to its complex effects on mood, perception, and cognition.
Effects[edit | edit source]
The effects of 1T-AL-LAD are similar to those of LSD, though users report subtle differences in the qualitative experience. Common effects include:
- Visual hallucinations and distortions
- Altered sense of time
- Enhanced introspection
- Emotional variability
- Synesthesia
The onset of effects typically occurs within 30 to 60 minutes after ingestion, with the peak experience lasting 4 to 6 hours, followed by a gradual return to baseline over several hours.
Safety and Toxicity[edit | edit source]
As with other psychedelics, the safety profile of 1T-AL-LAD is not fully understood, and it should be approached with caution. There is limited data on its toxicity, but it is generally considered to have a low potential for physical harm. However, psychological risks, such as anxiety and paranoia, can occur, particularly in individuals with a predisposition to mental health disorders.
Legal Status[edit | edit source]
The legal status of 1T-AL-LAD varies by country. In some jurisdictions, it is classified as a controlled substance, while in others, it remains unscheduled. Users should be aware of the legal implications of possessing or distributing this compound in their region.
Related Compounds[edit | edit source]
1T-AL-LAD is part of a broader family of lysergamides, which includes:
These compounds share similar structures and effects but differ in their potency, duration, and subjective experience.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD